News

The impact of long-acting injectables (LAIs) for HIV was discussed at the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria ...
A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups ...
At ESCMID Global, Microbix will be showcasing its QAPs innovations for helping to ensure the accuracy of diagnostic tests, including for bacterial, viral, and parasitic diseases, and in multiple ...
VIENNA, April 14, 2025 /PRNewswire/ -- Autonomous Medical Devices Incorporated (AMDI) today announced the launch of its newest innovation, the Autolab™ HBH system, at the ESCMID Global Congress ...
Healio will have live coverage of this year’s ESCMID Global, one of the largest medical conferences dedicated to infectious diseases and clinical microbiology in the world. The conference, known ...
Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program ResultsMISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a ...
Moderna will present twelve scientific presentations at the ESCMID 2025 Global Congress, ... Logo Brands Celebrates Grand Opening of New 342,000 Sq. Ft. Warehouse in Spring Hill, Tennessee ...
MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and ...
Moderna will present twelve scientific presentations at the ESCMID 2025 Global Congress, including three oral presentations, one e-poster presentation, and ...